Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of daptomycin during continuous venovenous hemofiltration
2009-016092-30Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2010
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of daptomycin in bacterial disease, sponsored by Medical University of Vienna. Primary endpoint: area under the curve (AUC). Started Jan 2010; status: completed.
02
Drugs
daptomycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2009-016092-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016092-30.